Immunotherapy, the use of the body's immune system to fight diseases, has revolutionized the field of oncology and holds promise for other areas of medicine. This guide provides an overview of the science behind immunotherapy, its current applications, and future directions.
Immunotherapy involves the enhancement or suppression of the immune system's response to disease. It can be active, passive, or adoptive. Active immunotherapy stimulates the patient's immune system to respond to an antigen, while passive immunotherapy involves the administration of preformed antibodies. Adoptive immunotherapy, on the other hand, involves the transfer of immune cells into a patient.
Immunotherapy has been most successful in the treatment of cancers, particularly melanoma, lung, bladder, and head and neck cancers. Checkpoint inhibitors, CAR-T cell therapy, and cancer vaccines are among the most common types of cancer immunotherapies. Additionally, immunotherapy is also being used in the management of autoimmune diseases such as rheumatoid arthritis and multiple sclerosis.
Research is ongoing to expand the use of immunotherapy to other diseases and to improve its efficacy in current applications. One area of focus is the development of combination therapies that use immunotherapy alongside other treatments. Personalized immunotherapies, which are tailored to an individual patient's immune response, are also being explored.
Immunotherapy represents a significant stride in modern healthcare, providing new hope for patients with diseases that were previously considered untreatable. As physicians, it is essential to stay abreast of these advancements to provide the best possible care to our patients. By understanding the principles of immunotherapy, we can better navigate this rapidly evolving field and harness its potential to improve patient outcomes.
1.
Tumor characteristics found to differ for melanomas in children, teens and young adults
2.
Unexplained CAR-T Death; Americans Spurn Sunscreen; Improving Diversity in Trials
3.
"A lot" of aspirin reduces the risk of ovarian cancer, regardless of genetic factors, according to the JAMA study.
4.
Approval in Endometrial Cancer Expanded; Masks at Cancer Centers; NPR Reporter Dies
5.
Is Lenalidomide Resistance in Myeloma Reversible with JAK Inhibition?
1.
Modern Oncology Unveiled with Treatment Innovations and Personalized Cancer Care
2.
Screening for Early Therapy-Related Cancer Susceptibility
3.
Unlocking the Potential of Bicalutamide 50 mg: A Revolutionary New Treatment for Prostate Cancer
4.
Skin-Sparing Mastectomy: Balancing Cancer Control with Cosmetic Results
5.
Reducing Modifiable Childhood Cancer Exposure Risks
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Dacomitinib Case Presentation: Baseline Treatment and Current Status
2.
Targeting Oncologic Drivers with Dacomitinib: Further Discussion on Lung Cancer Treatment
3.
Should We Use DARA Up Front As First-Line Therapy in MM?
4.
Iron Deficiency Anemia: Ferric Maltol As a New Treatment Option- A New Perspective
5.
Importance of Cancer Screening and Early Detection
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation